Provided by Tiger Trade Technology Pte. Ltd.

PolyPid Ltd.

3.92
-0.0100-0.25%
Volume:41.40K
Turnover:162.15K
Market Cap:65.21M
PE:-1.50
High:3.95
Open:3.93
Low:3.90
Close:3.93
52wk High:4.07
52wk Low:2.30
Shares:16.63M
Float Shares:10.06M
Volume Ratio:0.95
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6165
EPS(LYR):-4.9083
ROE:-390.53%
ROA:-87.91%
PB:4.24
PE(LYR):-0.80

Loading ...

PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress

GlobeNewswire
·
Sep 30

Roth MKM Sticks to Their Buy Rating for PolyPid (PYPD)

TIPRANKS
·
Sep 18

Craig-Hallum Sticks to Its Buy Rating for PolyPid (PYPD)

TIPRANKS
·
Sep 17

PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference

GlobeNewswire
·
Sep 17

PolyPid Completes Key GMP Inspection for D-PLEX100 Manufacturing Readiness

TIPRANKS
·
Sep 16

PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀

GlobeNewswire
·
Sep 16

PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference

GlobeNewswire
·
Sep 02

PolyPid Is Maintained at Buy by Craig-Hallum

Dow Jones
·
Aug 15

PolyPid Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 14

PolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

PolyPid Q2 EPS $(0.78) Misses $(0.55) Estimate

Benzinga
·
Aug 13

BRIEF-PolyPid Q2 Net Income USD -10 Million

Reuters
·
Aug 13

PolyPid Q2 EPS USD -0.78 VS. Ibes Estimate USD -0.55

THOMSON REUTERS
·
Aug 13

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

GlobeNewswire
·
Aug 12

PolyPid Ltd expected to post a loss of 55 cents a share - Earnings Preview

Reuters
·
Aug 11

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

GlobeNewswire
·
Jul 30

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

GlobeNewswire
·
Jul 15